advertisement
Lu DW 12
Showing records 1 to 12 | Display all abstracts from Lu DW118116 A multi-label transformer-based deep learning approach to predict focal visual field progression
Chen L
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 2227-2235
117535 Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial
Wang TH
Clinical Ophthalmology 2024; 18: 2093-2106
116828 The Role of Retinal Ganglion Cell Structure and Function in Glaucoma
Feng KM
Cells 2023; 12:
118116 A multi-label transformer-based deep learning approach to predict focal visual field progression
Tseng VS
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 2227-2235
117535 Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial
Aung T
Clinical Ophthalmology 2024; 18: 2093-2106
116828 The Role of Retinal Ganglion Cell Structure and Function in Glaucoma
Tsung TH
Cells 2023; 12:
117535 Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial
Lu DW
Clinical Ophthalmology 2024; 18: 2093-2106
118116 A multi-label transformer-based deep learning approach to predict focal visual field progression
Tsung TH
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 2227-2235
116828 The Role of Retinal Ganglion Cell Structure and Function in Glaucoma
Chen YH; Lu DW
Cells 2023; 12:
117535 Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial
George R
Clinical Ophthalmology 2024; 18: 2093-2106
118116 A multi-label transformer-based deep learning approach to predict focal visual field progression
Lu DW
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 2227-2235
117535 Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial
Senthil S; Lu F; Odani-Kawabata N; Park KH
Clinical Ophthalmology 2024; 18: 2093-2106
